Cytarabin Fresenius Kabi

Cytarabine is a chemotherapy drug used to treat certain types of cancer. It works by slowing or stopping the growth of cancer cells in the body. This medication is administered intravenously and is manufactured by Fresenius Kabi AB.

Cytarabine is primarily used in the treatment of various types of cancer, including acute myeloid leukemia and acute lymphoblastic leukemia. It is often used in combination with other chemotherapy drugs to enhance its effectiveness. Cytarabine works by interfering with the DNA synthesis in cancer cells, which helps to slow or stop their growth and proliferation.

Common effects of Cytarabine may include nausea, vomiting, and fatigue. Some patients may also experience fever, diarrhea, and a decreased appetite. These effects can vary in severity and may not affect everyone who takes the medication. It is important to discuss any concerns with a healthcare provider.

Cytarabine should be handled with care and administered under the supervision of a healthcare professional. It is important to follow all instructions provided by the healthcare provider to minimize the risk of side effects. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.

Cytarabine may interact with other medications, including certain antibiotics, antifungals, and other chemotherapy drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while taking Cytarabine, as it may increase the risk of side effects.